PMID: 7007669Mar 20, 1981Paper

Allogeneic bone marrow transplantation for 144 patients with severe aplastic anemia

JAMA : the Journal of the American Medical Association
M M BortinA A Rimm

Abstract

Comprehensive data were reported to the International Bone Marrow Transplant Registry by 24 worldwide teams regarding 144 patients with severe aplastic anemia who were treated with HLA-identical, allogeneic bone marrow transplantation between 1975 and 1978. One hundred fourteen patients received one transplant and 30 received two. Sustained engraftment of donor marrow occurred on the first transplant attempt in 76% of the patients whose engraftment status could be evaluated. Moderate, severe, or lethal graft-vs-host disease (GVHD) occurred in 52% of the engrafted patients. The one-year survival rate for all patients was 44% (64/144). Among the one-year survivors, the primary disease was apparently cured in 90% and improved in 10%. Thus far, four patients died one to five years after transplant. Of the 60 patients currently alive, ten have chronic GVHD and the remainder are in good health. Multivariate analyses of the data disclosed a number of pretransplant factors associated with engraftment, GVHD, and one-year survival. The most important finding was that the use of male donors was preferable to female donors because of a higher rate of engraftment, less severe GVHD, and a higher one-year survival rate.

Citations

Jan 1, 1984·Cancer Investigation·K M Sullivan, R Storb
Oct 1, 1983·Clinics in Haematology·R Storb, G W Santos
Oct 1, 1983·Clinics in Haematology·E J YunisC A Alper
Jun 1, 1988·International Journal of Radiation Oncology, Biology, Physics·B ShankR J O'Reilly
Mar 25, 1982·The New England Journal of Medicine·B M CamittaE D Thomas
Apr 10, 2002·International Journal of Hematology·George E Georges, Rainer Storb
Jan 10, 2001·Bone Marrow Transplantation·M FouladiM H Freedman
Jan 1, 1986·International Journal of Cell Cloning·K M Sullivan
Feb 1, 1989·Irish Journal of Medical Science·M MurrayS R McCann
Jan 1, 1991·International Journal of Technology Assessment in Health Care·A A RimmM M Bortin
Jul 2, 2002·Blood·Alvaro Urbano-IspizuaUNKNOWN Spanish Group for Allogeneic Peripheral Blood Transplantation (Grupo Español de Trasplante Hemopoyético) and Instituto Portu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.